The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Effect of Partial Ileal Bypass Surgery on Mortality and Morbidity from Coronary Heart Disease in Patients with Hypercholesterolemia: Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH)
Open accessAbstract
BACKGROUND AND METHODS: The Program on the Surgical Control of the Hyperlipidemias (POSCH), a randomized clinical trial, was designed to test whether cholesterol lowering induced by the partial ileal bypass operation would favorably affect overall mortality or mortality due to coronary heart disease. The study population consisted of 838 patients (417 in the control group and 421 in the surgery group), both men (90.7 percent) and women, with an average age of 51 years, who had survived a first myocardial infarction. The mean follow-up period was 9.7 years. RESULTS: When compared with the control group at five years, the surgery group had a total plasma cholesterol level 23.3 percent lower (4.71 +/- 0.91 vs. 6.14 +/- 0.89 mmol per liter [mean +/- SD]; P less than 0.0001), a low-density lipoprotein cholesterol level 37.7 percent lower (2.68 +/- 0.78 vs. 4.30 +/- 0.89 mmol per liter; P less than 0.0001), and a high-density lipoprotein cholesterol level 4.3 percent higher (1.08 +/- 0.26 vs. 1.04 +/- 0.25 mmol per liter; P = 0.02). Overall mortality and mortality due to coronary heart disease were reduced, but not significantly so (deaths overall [control vs. surgery], 62 vs. 49, P = 0.164; deaths due to coronary disease, 44 vs. 32, P = 0.113). The overall mortality in the surgery subgroup with an ejection fraction greater than or equal to 50 percent was 36 percent lower (control vs. surgery, 39 vs. 24; P = 0.021). The value for two end points combined--death due to coronary heart disease and confirmed nonfatal myocardial infarction--was 35 percent lower in the surgery group (125 vs. 82 events; P less than 0.001). During follow-up, 137 control-group and 52 surgery-group patients underwent coronary-artery bypass grafting (P less than 0.0001). A comparison of base-line coronary arteriograms with those obtained at 3, 5, 7, and 10 years consistently showed less disease progression in the surgery group (P less than 0.001). The most common side effect of partial ileal bypass was diarrhea; others included occasional kidney stones, gallstones, and intestinal obstruction. CONCLUSIONS: Partial ileal bypass produces sustained improvement in the blood lipid patterns of patients who have had a myocardial infarction and reduces their subsequent morbidity due to coronary heart disease. The role of this procedure in the management of hypercholesterolemia remains to be determined. These results provide strong evidence supporting the beneficial effects of lipid modification in the reduction of atherosclerosis progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Specifically, each 1-mmol/L reduction in LDL-C was associated with an RR of 0.75 (95% CI, 0.66-0.86;P = .002)in major vascular events”
From Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis (2016) · cites this paper as [51]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Practical Nonparametric Statistics
Groggel, D. J., & Conover, W. J. (2000) · Technometrics · doi:10.2307/1271101 · Cited by 11,076
Immunochemical quantitation of antigens by single radial immunodiffusion
Mancini, G., Carbonara, A. O., & Heremans, J. F. (1965) · Immunochemistry · doi:10.1016/0019-2791(65)90004-2 · Cited by 9,091
Hubert, H. B., Feinleib, M., McNamara, P. M., & Castelli, W. P. (1983) · Circulation · doi:10.1161/01.cir.67.5.968 · Cited by 4,241
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
Frick, M. H., Elo, O., Haapa, K., Heinonen, O. P., Heinsalmi, P., Helo, P., Huttunen, J. K., Kaitaniemi, P., Koskinen, P., Manninen, V., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711123172001 · Cited by 3,881
A Generalized Wilcoxon Test for Comparing Arbitrarily Singly-Censored Samples
Gehan, E. A. (1965) · Biometrika · doi:10.1093/biomet/52.1-2.203 · Cited by 3,407
Incidence of Coronary Heart Disease and Lipoprotein Cholesterol Levels
Castelli, W. P. (1986) · JAMA · doi:10.1001/jama.256.20.2835 · Cited by 2,512
Peto, R., Pike, M. C., Armitage, P., Breslow, N. E., Cox, D. R., Howard, S. V., Mantel, N., McPherson, K., Peto, J., & Smith, P. G. (1976) · British Journal of Cancer · doi:10.1038/bjc.1976.220 · Cited by 2,294
Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study.
Kannel, W., Castelli, W., Gordon, T., & McNamara, P. M. (2020) · Annals of Internal Medicine · doi:10.7326/0003-4819-74-1-1 · Cited by 2,160
Research works printed but not linked: 29
- 10.1001/jama.256.20.2823 · DOI · Paper page
- Leren, 1966, Acta Med Scand Suppl, 466, 1
- 1968, Lancet, 2, 693
- Frantz, 1975, Circulation, 52, II-4
- 10.1001/jama.231.4.360 · DOI
- 10.1001/jama.251.3.351 · DOI · Paper page
- 10.1001/jama.257.23.3233 · DOI
- Buchwald H. Intestinal bypass for hypercholesterolemia. In: Nyhus LM, Baker RJ, eds. Mastery of surgery. Vol. 3. Boston: Little, Brown, 1984:901–7.
- Buchwald H, Campos CT. Partial ileal bypass for control of hyperlipidemia and atherosclerosis. In: Sabiston DC Jr, Spencer FC, eds. Surgery of the chest. 5th ed. Philadelphia: W.B. Saunders, 1990:1799–819.
- Schouten, 1986, Artery, 13, 240
- 1959, Stat Bull Metrop Life Insur Co, 40, 1
- Bruce, 1971, Ann Clin Res, 3, 323
- National Heart and Lung Institute, Lipid Research Clinics Program. Manual of laboratory operations. Vol. 1. Bethesda, Md.: National Institutes of Health, 1974. (DHEW publication no. (NIH) 75–628.)
- 1970, Bull World Health Organ, 43, 891
- Mantel, 1966, Cancer Chemother Rep, 50, 163
- Matts, Controlled Clin Trials
- Campos, 1987, Surgery, 102, 424
- Campos, 1988, Curr Surg, 45, 380
- Campos, 1988, Surg Forum, 39, 193
- Addison, 1851, Guys Hosp Rep, 2, 267
- Ignatovski, 1908, Izviest Imp Voyenno-med Akad S Petersb, 16, 154
- Anitschkow, 1913, Centralbl Allg Pathol Pathol Anat, 24, 1
- Wacker, 1913, Münchener Med Wochenschr, 60, 2097
- European Coronary Surgery Study Group, 1982, Lancet, 2, 1173
- Buchwald, 1965, Surgery, 58, 22
- Scott, 1967, Surg Gynecol Obstet, 125, 3
- Buchwald, 1963, Circulation, 28, II-649
- Moore, 1969, Surgery, 65, 98
- Buchwald, Ann Surg
Cited by
Sorted by citations
Items 401–500 of 1,000
Effects of Colestipol Alone and in Combination With Simvastatin on Apolipoprotein B Metabolism
Gaw, A., Packard, C. J., Lindsay, G., Murray, E. F., Griffin, B. A., CASLAKE, M. J., Colquhoun, I. W., Wheatley, D. J., Lorimer, A. R., & Shepherd, J. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.2.236 · Cited by 25
Sylvan, A., Rutegård, M., Janunger, K. G., Sjölund, B., & Nilsson, T. (1992) · Metabolism · doi:10.1016/0026-0495(92)90110-v · Cited by 25
Review of Recent Clinical Trials of Lipid Lowering in Coronary Artery Disease
Smith, S. C. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00815-1 · Cited by 25
Gould, K. L. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00140-5 · Cited by 25
Hemphill, L. (2010) · Journal of clinical lipidology · doi:10.1016/j.jacl.2010.08.013 · Cited by 24
Vega, G. L., Dunn, F. L., & Grundy, S. M. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.06.011 · Cited by 23
Atualização da Diretriz Brasileira de Hipercolesterolemia Familiar – 2021
Izar, M. C. D. O., Rocha, V. Z., Bertolami, A., Santos, R. D., Lottenberg, A. M., Assad, M. H. V., Saraiva, J. F. K., Chacra, A. P. M., Martinez, T. L. D. R., Bahia, L., et al. (2021) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20210788 · Cited by 35
Pathogenesis of nephrolithiasis post-partial ileal bypass surgery: Case-control study
Obialo, C. I., Clayman, R. V., Matts, J. P., Fitch, L. L., Buchwald, H., Gillis, M., Hruska, K. A., & The Posch Group (1991) · Kidney International · doi:10.1038/ki.1991.158 · Cited by 23
Self-citationDecreased blood oxygen diffusion in hypercholesterolemia
Menchaca, H. J., Michalek, V. N., Rohde, T. D., O’Dea, T. J., & Buchwald, H. (1998) · Surgery · doi:10.1067/msy.1998.90944 · Cited by 23
Self-citationDyslipidemia and coronary artery disease
Kuo, P. T. (1994) · Clinical Cardiology · doi:10.1002/clc.4960171003 · Cited by 23
Ofori, A., Keeton, J., Booker, Q., Schneider, B. E., McAdams, C. J., & Messiah, S. E. (2020) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2020.01.031 · Cited by 23
Lipid-altering agents: the future
Wierzbicki, A. S. (2004) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2004.00087.x · Cited by 23
Stark, R. M. (1996) · American Journal of Cardiology · doi:10.1016/s0002-9149(96)00657-1 · Cited by 20
Gaw, A. (1996) · Atherosclerosis · doi:10.1016/0021-9150(96)05887-x · Cited by 23
Landmesser, U., Lindgren, P., Hagström, E., van Hout, B., Villa, G., Pemberton-Ross, P. J., Arellano, J., Svensson, M. K. E., Sibartie, M., & Fonarow, G. C. (2020) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcaa072 · Cited by 22
Adams, T. D., Davidson, L. E., Litwin, S. E., & Hunt, S. C. (2012) · Current Atherosclerosis Reports · doi:10.1007/s11883-012-0286-4 · Cited by 21
Intentional weight loss and risk of lymphohematopoietic cancers
Roos, A. J. D., Ulrich, C. M., Ray, R. M., Mossavar‐Rahmani, Y., Rosenberg, C. A., Caan, B. J., Thomson, C. A., McTiernan, A., & LaCroix, A. Z. (2009) · Cancer Causes & Control · doi:10.1007/s10552-009-9453-5 · Cited by 22
Why cholesterol as a central theme in coronary artery disease?
Sacks, F. M. (1998) · American Journal of Cardiology · doi:10.1016/s0002-9149(98)00717-6 · Cited by 18
Clinical perspectives on primary and secondary prevention of coronary atherosclerosis
DEEDWANIA, P. C. (1995) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)30017-7 · Cited by 23
Review of cholesterol-lowering therapy: Coronary angiographic and events trials
Waters, D. D., & Pedersen, T. R. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)00318-x · Cited by 22
Angiographic trials of lipid-lowering therapy: end of an era?
Thompson, G. R. (1995) · Heart · doi:10.1136/hrt.74.4.343 · Cited by 22
Syvänne, M., Taskinen, M., Nieminen, M. S., Manninen, V., Kesäniemi, Y. A., Pasternack, A. I., Nawrocki, J. W., Haber, H. E., & Frick, M. H. (1997) · Controlled Clinical Trials · doi:10.1016/s0197-2456(96)00091-8 · Cited by 22
Control de la colesterolemia en España, 2000: un instrumento para la prevención cardiovascular
Pérez, I. P., Álvarez, F. V., López, P. M., Jiménez, F. P., Galán, A. M., Lenguas, J. A. C., Banegas, J. R. B., Abadal, L. T., Rodríguez‐Artalejo, F., & López, E. G. (2000) · Revista Clínica Española · doi:10.1016/s0014-2565(00)70705-3 · Cited by 22
Changes in HDL cholesterol and cardiovascular outcomes after lipid modification therapy
Ray, K. K., Wainwright, N. W. J., Visser, L. E., Witteman, J. C. M., Breteler, M. M. B., Ambegaonkar, B. M., Albert Hofman, D., Stricker, B. H. C., Wareham, N. J., Khaw, K., et al. (2012) · Heart · doi:10.1136/heartjnl-2011-301405 · Cited by 21
Ara, R., Pandor, A., Tumur, I., Paisley, S., Duenas, A., Williams, R., Rees, A., Wilkinson, A., Durrington, P. N., & Chilcott, J. B. (2008) · American Journal of Cardiovascular Drugs · doi:10.2165/0129784-200808060-00005 · Cited by 21
Citation classics: Top 50 cited articles in bariatric and metabolic surgery
Aminian, A., Daigle, C. R., Brethauer, S. A., & Schauer, P. R. (2014) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2013.12.021 · Cited by 21
Waters, D. D., & Lespérance, J. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90051-x · Cited by 21
Buchwald, H., Campos, C. T., Matts, J. P., Fitch, L. L., Long, J. M., & Varco, R. L. (1992) · Annals of Surgery · doi:10.1097/00000658-199210000-00001 · Cited by 21
Self-citationModification of coronary artery disease progression by cholesterol-lowering therapy
Archbold, A., & Timmis, A. (1999) · Current Opinion in Lipidology · doi:10.1097/00041433-199912000-00008 · Cited by 20
Foster, G. P., Mittleman, M. A., Koch, M., Abela, G. S., & ZARICH, S. W. (1997) · Clinical Cardiology · doi:10.1002/clc.4960200105 · Cited by 21
Chrisp, P., Lewis, N. J. W., & Milne, R. J. (1992) · PharmacoEconomics · doi:10.2165/00019053-199201020-00009 · Cited by 20
Wirebaugh, S. R., Shapiro, M. L., McLntyre, T. H., & Whitney, E. (1992) · Pharmacotherapy · doi:10.1002/j.1875-9114.1992.tb04487.x · Cited by 21
Ramos-Levi, A. M., & Rubio, M. Á. (2013) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2013.04.006 · Cited by 20
LDL-Cholesterol: Standards of Treatment 2016: A German Perspective
März, W., Scharnagl, H., Gouni‐Berthold, I., Silbernagel, G., Dressel, A., Grammer, T. B., Landmesser, U., Dieplinger, H., Windler, E., & Laufs, U. (2016) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-016-0179-y · Cited by 20
Grover, S. A., Coupal, L., & Lowensteyn, I. (2008) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(08)70695-0 · Cited by 20
Lansky, A. J., Desai, K., & Leon, M. B. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)02326-8 · Cited by 20
Effect of ascorbic acid on prevention of hypercholesterolemia induced atherosclerosis
Das, S., Ray, R., Snehlata, S., Das, N., & Srivastava, L. M. (2006) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-005-9070-x · Cited by 20
Korpilahti, K. (1998) · European Heart Journal · doi:10.1053/euhj.1997.0869 · Cited by 20
Current Topics on Low‐Density Lipoprotein Apheresis
Bambauer, R., Schiel, R., & Latza, R. (2001) · Therapeutic Apheresis and Dialysis · doi:10.1046/j.1526-0968.2001.00359.x · Cited by 20
Low blood total cholesterol and mortality: causality, consequence and confounders.
Lewis, B. J., & Tikkanen, M. J. (1994) · American Journal of Cardiology · doi:10.1016/0002-9149(94)90731-5 · Cited by 27
Dueland, S., France, D. S., Wang, S. L., Trawick, J. D., & Davis, R. A. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37426-5 · Cited by 20
Efficacy Studies in Coronary Rehabilitation
Bittner, V., & Oberman, A. (1993) · Cardiology Clinics · doi:10.1016/s0733-8651(18)30183-8 · Cited by 20
Clavijo, L., Caro, J., Choi, J., Caro, J. A., Tun, H. W., Rowe, V. L., Kumar, S. R., Shavelle, D. M., & Matthews, R. V. (2023) · Cardiovascular revascularization medicine · doi:10.1016/j.carrev.2023.04.020 · Cited by 19
Cholesterol lowering and coronary artery disease: mechanisms of risk reduction
Archbold, A., & Timmis, A. (1998) · Heart · doi:10.1136/hrt.80.6.543 · Cited by 19
Matts, J. P. (1995) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)00145-g · Cited by 19
Self-citationThe rapid reduction in cardiac events with lipid-lowering therapy: mechanisms and implications.
Pearson, T. A., & Marx, H. J. (1993) · American Journal of Cardiology · doi:10.1016/0002-9149(93)90864-9 · Cited by 21
Gostin, L. (1991) · New England Journal of Medicine · doi:10.1056/nejm199112193252517 · Cited by 19
Waters, D. D., Higginson, L., Gladstone, P. J., Kimball, B. P., Lemay, M., & Lespérance, J. (1993) · Controlled Clinical Trials · doi:10.1016/0197-2456(93)90049-j · Cited by 16
Surgical procedures and devices should be evaluated in the same way as medical therapy
Buchwald, H. (1997) · Controlled Clinical Trials · doi:10.1016/s0197-2456(96)00114-6 · Cited by 18
Self-citationSasser, T., Buddhiraju, C., Kumar, V. B., López‐Candales, A., Grosjlos, J., Scherrer, D. E., & Lange, L. G. (1996) · Biochemistry and Cell Biology · doi:10.1139/o96-027 · Cited by 18
Cook, J. R., Yin, D., Alemao, E., & Drummond, M. (2004) · PharmacoEconomics · doi:10.2165/00019053-200422003-00005 · Cited by 18
Charlson, M. E. (2002) · Health Education Research · doi:10.1093/her/17.5.606 · Cited by 20
THE ROLE OF CHOLESTEROL MANAGEMENT IN CORONARY DISEASE RISK REDUCTION IN ELDERLY PATIENTS
Grundy, S. M. (1998) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70032-3 · Cited by 18
Herd, J. A., West, M. S., Ballantyne, C. M., Farmer, J. A., & Gotto, A. M. (1994) · The American Journal of Cardiology · doi:10.1016/0002-9149(94)90632-7 · Cited by 18
The Rationale for Lowering Serum Cholesterol Levels in American Children
Gidding, S. S. (1993) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.1993.02160280036014 · Cited by 18
Tollefson, M. B., Vernier, W. F., Huang, H. T., Chen, F. P., Reinhard, E. J., Beaudry, J. A., Keller, B. T., & Reitz, D. B. (2000) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(99)00683-6 · Cited by 18
Abrams, J., Coultas, D., Malhotra, D. K., Vela, B. S., Samaan, S. A., & Roche, R. J. (1995) · Current Problems in Cardiology · doi:10.1016/s0146-2806(06)80023-x · Cited by 18
Lipid risk factors and the regression of atherosclerosis.
Gotto, A. (1995) · American Journal of Cardiology · doi:10.1016/s0002-9149(05)80009-8 · Cited by 22
Successful management of primary hypercholesterolaemia with simvastatin and low‐dose colestipol
Simons, L. A., Simons, J., & Parfitt, A. (1992) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1992.tb137306.x · Cited by 18
Brown, B. G., Hillger, L. A., Zhao, X.-Q., Sacco, D. E., Bisson, B., & Fisher, L. D. (1993) · Developments in cardiovascular medicine · doi:10.1007/978-94-011-1854-5_18 · Cited by 18
Lowering cholesterol: effects on trauma death, cancer death and total mortality
MacMahon, S. W. (1992) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.1992.tb00481.x · Cited by 18
Hirayama, S., Nakagawa, S., Soda, S., Kamimura, Y., Nishioka, E., Ueno, T., Fukushima, Y., Higuchi, K.-I., Inoue, M., Seino, U., et al. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.06.016 · Cited by 17
Agishi, T., Wood, W., & Gordon, B. (1994) · Current Therapeutic Research · doi:10.1016/s0011-393x(05)80579-x · Cited by 18
To statin or to non-statin in coronary disease—considering absolute risk is the answer
Rembold, C. M. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.09.009 · Cited by 17
Bonge, H., Hallén, S., Fryklund, J., & Sjöström, J.-E. (2000) · Analytical Biochemistry · doi:10.1006/abio.2000.4600 · Cited by 17
Cholesterol and cardiovascular disease: hOw strong is the evidence?
LaRosa, J. C. (1992) · Clinical Cardiology · doi:10.1002/clc.4960151003 · Cited by 14
Effects of atorvastatin on in-stent stenosis in normo- and hypercholesterolemic rabbits
Herdeg, C., Fitzke, M., Oberhoff, M., Baumbach, A., Schroeder, S., & Karsch, K. R. (2003) · International Journal of Cardiology · doi:10.1016/s0167-5273(02)00588-0 · Cited by 17
Pathogenesis and Pathology of Coronary Heart Disease Syndromes
Ridker, P. M., & Antman, E. M. (1999) · Journal of Thrombosis and Thrombolysis · doi:10.1023/a:1008997801820 · Cited by 17
ROLE OF THE ENTEROHEPATIC CIRCULATION OF BILE SALTS IN LIPOPROTEIN METABOLISM
Cooper, A. D. (1999) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(05)70051-0 · Cited by 18
Koga, N. (1997) · Therapeutic apheresis · doi:10.1111/j.1744-9987.1997.tb00149.x · Cited by 20
Nakamura, Y., Yamaoka, O., Uchida, K., Morigami, N., Sugimoto, Y., Fujita, T., Inoue, T., Fuchi, T., Hachisuka, M., Ueshima, H., et al. (1996) · Cardiovascular Drugs and Therapy · doi:10.1007/bf00051114 · Cited by 17
Coronary angiography: more than meets the eye.
Applegate, R. J., Herrington, D. M., & Little, W. C. (1993) · Circulation · doi:10.1161/01.cir.87.4.1399 · Cited by 19
Grundy, S. M. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00462-2 · Cited by 17
Program on the surgical control of the hyperlipidemias (POSCH): Patient entry characteristics
Matts, J. P., Buchwald, H., Fitch, L. L., Campos, C. T., Varco, R. L., Campbell, G. S., Pearce, M. B., Yellin, A. E., Edmiston, W. A., Smink, R. D., et al. (1991) · Controlled Clinical Trials · doi:10.1016/0197-2456(91)90028-k · Cited by 17
Self-citationGould, K. L. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90275-r · Cited by 17
O’Keefe, J. H., Cordain, L., Jones, P. G., & Abuissa, H. S. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.01.062 · Cited by 17
Coronary atheroma regression trials
Oliver, M. F., Elliott, J. M., White, H. D., Seed, P. T., Ramsay, L. E., Yeo, W. W., Jackson, P. R., Watts, G. F., Lewis, B., Brunt, J. N. H., et al. (1992) · The Lancet · doi:10.1016/0140-6736(92)91189-f · Cited by 16
Watts, G. F., Pang, J., Chan, D. C., Brunt, J. N. H., & Lewis, B. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.07.923 · Cited by 16
Ozaki, K., Yamamoto, T., Ishibashi, T., Matsubara, T., Nishio, M., & Aizawa, Y. (2001) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.85.147 · Cited by 16
Buchwald, H., Fitch, L. L., Matts, J. P., Johnson, J. W., Hansen, B. J., Stuenkel, M., & Brooks, H. B. (1993) · Controlled Clinical Trials · doi:10.1016/0197-2456(93)90030-h · Cited by 16
Self-citationCholesterol and coronary heart disease mortality
Sleight, P. (1992) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.1992.tb00480.x · Cited by 16
Cardiac rehabilitation. Current status and future directions.
Gattiker, H., Goins, P., & Dennis, C. A. (1992) · PubMed Central · Cited by 16
Holme, I. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00083-6 · Cited by 11
Lane, D. M., McConathy, W. J., Laughlin, L. O., Comp, P. C., von Albertini, B., Gibson, S. M., Bricker, L. A., Kozlovskis, P. L., & Dorrier, C. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90830-6 · Cited by 16
Geurian, K. (1996) · The Annals of Pharmacotherapy · doi:10.1177/106002809603000512 · Cited by 9
Wierzbicki, A. S. (2003) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.8.2.365 · Cited by 16
Cardiovascular risk changes after lipid lowering medications: are they predictable?
Sirtori, C. R., Calabresi, L., Marchioli, R., & Bloomfield, H. E. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(00)00551-7 · Cited by 16
Plasma Lipid Concentrations and Subsequent Coronary Occlusion After a First Myocardial Infarction
Bissett, J. K., Wyeth, R. P., Matts, J. P., & Johnson, J. W. (1993) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199303000-00002 · Cited by 16
Self-citationMack, W. J., Selzer, R. H., Pogoda, J. M., Lee, P. L., Shircore, A. M., Azen, S. P., & Blankenhorn, D. H. (1992) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.12.3.348 · Cited by 16
van Nooten, F. E., Davies, G. M., Jukema, J. W., Liem, A. H., Yap, E., & Hu, X. (2011) · Netherlands Heart Journal · doi:10.1007/s12471-010-0061-5 · Cited by 15
A review of statin use in patients with acute coronary syndrome in Western and Japanese populations
Miyauchi, K., & Ray, K. K. (2013) · Journal of International Medical Research · doi:10.1177/0300060513476428 · Cited by 15
Alghamdi, A. A., Balkhi, B. S., Altowaijri, A. I., Alshehri, N., Ralph, L., Marriott, E.-R., Urbich, M., Aljanad, F., & Aziziyeh, R. (2021) · PharmacoEconomics - Open · doi:10.1007/s41669-021-00300-8 · Cited by 15
Dietary Counselling for Dyslipidemia in Primary Care: Results of a Randomized Trial
Reid, R. D., Fodor, G. J., Lydon-Hassen, K., D’Angelo, M. S., McCrea, J., Bowlby, M. C., & DiFrancesco, L. (2002) · Canadian Journal of Dietetic Practice and Research · doi:10.3148/63.4.2002.169 · Cited by 15
Pharmacological prevention of atherothrombotic events in patients with peripheral arterial disease
Blinc, A., & Poredoš, P. (2007) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2007.01767.x · Cited by 15
Meta-analysis of clinical trials: a consumer's guide
Geller, N. L., & Proschan, M. A. (1996) · Journal of Biopharmaceutical Statistics · doi:10.1080/10543409608835151 · Cited by 15
Mortality Experience in Cholesterol-Reduction Trials
Muldoon, M. F., Manuck, S. B., & Matthews, K. A. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103283241313 · Cited by 15
Coronary Artery Disease Prevention
Sherazi, S., & Block, R. (2009) · Springer eBooks · doi:10.1007/978-1-84882-185-9_2 · Cited by 15
Appropriateness of Dyslipidemia Management Strategies in Post-Acute Coronary Syndrome: A 2023 Update
Lucà, F., Oliva, F. G., Rao, C. M., Abrignani, M. G., Amico, A. F., Fusco, S. A. D., Caretta, G., Matteo, I. D., Nora, C. D., Pilleri, A., et al. (2023) · Metabolites · doi:10.3390/metabo13080916 · Cited by 17
Mori, K., Ishida, T., Tsuda, S., Oshita, T., Shinohara, M., Hara, T., Irino, Y., Toh, R., & Hirata, K. (2016) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.32615 · Cited by 14
Development of an avian model for restenosis
Lucas, A. R., Wen, Y., Jiang, X. Y., Liu, L.-Y., Yan, W.-D., Bauer, J., Schneider, W., TULIP, J., Chagpar, A. B., Dai, E., et al. (1996) · Atherosclerosis · doi:10.1016/0021-9150(95)05626-2 · Cited by 14
Metadata
- Authors
- Buchwald, H., Varco, R. L., Matts, J. P., Long, J. M., Fitch, L. L., Campbell, G. S., Pearce, M. B., Yellin, A. E., Edmiston, W. A., Smink, R. D., Sawin, H. S., Campos, C. T., Hansen, B. J., Tuna, N., Karnegis, J. N., Sanmarco, M. E., Amplatz, K., Castaneda-Zuniga, W. R., Hunter, D. W., Bissett, J. K., Weber, F. J., Stevenson, J. W., Leon, A. S., & Chalmers, T. C.
- Affiliations
- University of Minnesota (US)
- University of Southern California (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1990-10-04
- Volume
- 323
- Issue
- 14
- Pages
- 946-955
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2331959986
- Cited by
- 1,001
- References
- 58
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 3 · 2023: 9 · 2022: 5 · 2021: 20 · 2020: 11 · 2019: 16 · 2018: 10 · 2017: 11 · 2016: 22 · 2015: 15 · 2014: 17 · 2013: 12 · 2012: 17
- FWCI
- 84.71
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Surgery › Cardiac and Coronary Surgery Techniques
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- partial ileal bypass, hypercholesterolemia, coronary artery disease, mortality, myocardial infarction, cholesterol lowering, LDL cholesterol, HDL cholesterol, first myocardial infarction, coronary artery bypass grafting, ejection fraction, long-term outcomes, nonfatal myocardial infarction
- MeSH terms
- Adult, Coronary Disease, Electrocardiography, Female, Follow-Up Studies, Humans, Hypercholesterolemia, Hyperlipidemias, Jejunoileal Bypass, Lipids, Male, Middle Aged, Ultrasonography, Multicenter Studies as Topic, Randomized Controlled Trials as Topic, Coronary Angiography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review